Author Archives: Walter Armstrong

Why Won’t Andrew Witty Take the Dive? (Updated 7/30/10)

By Walter Armstrong | Published: July 29, 2010
AIDS: An epidemic without end. It’s mostly fallen off the front pages—who has time or money or compassion for a decades-old global health crisis when we’ve got our own global economic crisis?—except for every two years when the International AIDS Conference comes around. The one held in Vienna last week earned some ink, but the [...]
Posted in Strategy | 2 Comments

Avandia on Trial

By Walter Armstrong | Published: July 12, 2010
The mid-July FDA advisory committee meeting to decide the fate of GlaxoSmithKline’s Avandia (rosiglitazone) is widely viewed as a test case of how the agency’s new leadership will address controversial drugs with serious risks but confusing data. A request that GSK yank its diabetes blockbuster—three years after first being associated with an increased risk of [...]
Posted in Legal | Tagged , , , , , , , | Leave a comment

Government Crackdown on the C-Suite

By Walter Armstrong | Published: June 2, 2010
Over the past decade, the drug industry has paid tens of billions of dollars to settle state and federal lawsuits involving the False Claims Act—defrauding Medicare and Medicaid, promoting drugs for unapproved uses, paying kickbacks to doctors and pharmacies, and the like. Stories about off-label promotion of drugs with serious adverse effects and no proven [...]
Posted in Legal | Tagged , , , , , | Leave a comment

When Big Pharma Leaves Town

By Walter Armstrong | Published: November 16, 2009
Image via Wikipedia Wall Street smiles when a drug company gets with the program by “restructuring” and “rightsizing”—cutting costs through headline-grabbing layoffs. But for Main Street, the story of hundreds or thousands of sales reps, say, and researchers getting kicked to the curb is quite different. The two gi-normous mergers that closed in the past month offer [...]
Posted in Strategy | Tagged , , , , , , , | 2 Comments

Tauzin to Boehner: Don’t “Bully” Me

By Walter Armstrong | Published: August 19, 2009
Image via Wikipedia PhRMA chief Billy Tauzin so far shows no sign of waving the white flag in response to an accusatory missive from House Minority Leader Rep. John Boehner bludgeoning his former Republican colleague for leading the drug industry’s support of President Obama’s healthcare reform effort. Pointedly CC’d to pharma CEOs – Tauzin’s employers—and simultaneously [...]
Posted in Regulatory | Tagged , , , , , , , | Leave a comment